A randomised control trial to test an educational innovation of diabetes care in general practice
Not Applicable
- Conditions
- Type 2 DiabetesMetabolic and Endocrine - DiabetesPublic Health - Health promotion/education
- Registration Number
- ACTRN12612000747820
- Lead Sponsor
- Professor Moyez Jiwa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Participants will be general practitioners (GPs) registered with the appropriate state authority and working in community-based practices across Australia.
Actors to take part in the simulated consultations will be recruited from an existing pool of actors the research team has used previously.
Exclusion Criteria
GP participants will be excluded from the study if they are unable to provide informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does Spaced Education Diabetes compare to traditional CME in improving HbA1c control for type 2 diabetes patients in primary care?
What biomarkers correlate with enhanced metabolic outcomes in type 2 diabetes patients managed by GPs using Spaced Education Diabetes?
What are the potential adverse effects of implementing Spaced Education Diabetes in general practice for type 2 diabetes management?
How does Spaced Education Diabetes influence adherence to SGLT2 inhibitor or GLP-1 agonist guidelines in type 2 diabetes care?
What molecular mechanisms underlie the effectiveness of Spaced Education Diabetes in optimizing metabolic targets for type 2 diabetes?